approval
saveLAMOTRIGINE — FDA approval
community read0 votes
Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalLAMOTRIGINE — FDA approvalApr 17, 2026 · 176d ago
- approvalLAMOTRIGINE — FDA approvalApr 17, 2026 · 176d ago
- approvalLAMOTRIGINE — FDA approvalApr 10, 2026 · 183d ago
- approvalLAMOTRIGINE — FDA approvalApr 10, 2026 · 183d ago
- approvalLAMOTRIGINE — FDA approvalApr 10, 2026 · 183d ago
- approvalLAMOTRIGINE — FDA approvalApr 10, 2026 · 183d ago
- approvalLAMOTRIGINE — FDA approvalApr 10, 2026 · 183d ago
- approvalLAMOTRIGINE — FDA approvalApr 9, 2026 · 184d ago
same company · ±60 days · 6
- approvalLAMOTRIGINE: LAMOTRIGINE — FDA approvalApr 18, 2017
- approvalLAMOTRIGINE: LAMOTRIGINE — FDA approvalApr 18, 2017
- approvalALDACTAZIDE: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalApr 24, 2017
- approvalondansetron ODT: ONDANSETRON — FDA approvalMar 27, 2017
- approvalondansetron ODT: ONDANSETRON — FDA approvalMar 27, 2017
- approvalondansetron hydrochloride CR: ONDANSETRON HYDROCHLORIDE — FDA approvalMar 27, 2017
comments(0)
5-min edit window · permanent after that